Piper Sandler Companies appointed Stuart M. Essig, Ph.D. to its board of directors.

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Stuart M. Essig, Ph.D. to its board of directors.

"Stuart will be a great asset to our board of directors. He brings deep experience and knowledge of the healthcare and medical technology industries, which remain important sectors for our investment banking business. In addition, his proven track record of leading a growing, publicly traded company will provide valuable perspective to the board," said Chad Abraham, Piper Sandler chairman and chief executive officer.

Essig previously served as chief executive officer and director of Integra LifeSciences Corporation, a global medical technology company focused on innovative solutions for neurosurgery, tissue reconstruction, and advanced wound care, from 1997 to 2012. Following that, he has served as chairman from 2012 until today and executive chairman during 2024 and 2025. During Essig's tenure, Integra LifeSciences grew revenues from approximately $15 million to more than $1.6 billion. Before joining Integra, Essig was a managing director in the healthcare group at Goldman Sachs where he had 10 years of experience, serving as a senior mergers and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients.

In addition to serving as chairman of Integra, Essig currently serves on the board of directors at IDEXX Laboratories. From 1999 to 2017, he served on the board of directors at St. Jude Medical and has also sat on the boards of Zimmer Biomet, Owens & Minor and Orthofix. Essig earned a bachelor's degree from the School of Public and International Affairs at Princeton University, and M.B.A. and Ph.D. degrees in financial economics from the University of Chicago, Graduate School of Business.

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon
COMTEX_473342728/2227/2026-02-11T14:16:11